• Home
  • Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.

Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.

Author List
Kieuhoa T. Vo, Jennifer G. Michlitsch, Avanthi T. Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham, Fabienne Hollinger, Matthew A. Zapala, Janel Long-Boyle, Mi-Ok Kim, Katherine K. Matthay, Steven G. DuBois
Publication
Journal of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/117442101
Publication Year
2020
Publication Title
Kieuhoa T. Vo, Jennifer G. Michlitsch, Avanthi T. Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham, Fabienne Hollinger, Matthew A. Zapala, Janel Long-Boyle, Mi-Ok Kim, Katherine K. Matthay, Steven G. DuBois. Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):10526-10526.